Skip to main content
Erschienen in:

05.05.2024 | Maternal-Fetal Medicine

Adnexal masses and pregnancy: a single-center experience of 9 years

verfasst von: Rıza Dur, Erhan Demirdag, Ozge Yucel Celik, Ertugrul Karahanoglu, Gamze Dur, Cem Yagmur Ozdemir, Aykan Yucel, Ozlem Moraloglu Tekin

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aims to analyze the experience of a tertiary health center about the management of adnexal masses that have been diagnosed during pregnancy or detected accidentally during cesarean delivery.

Methods

This is a retrospective review of 160 women who underwent concurrent surgery for adnexal mass during cesarean section, 24 women who delivered vaginally and subsequently had surgery due to the prenatal diagnosis of adnexal mass and 10 women who underwent surgery for adnexal mass during pregnancy. Corresponding to the delivery and surgery times, 200 women who had no diagnosis of pregnancy-associated adnexal mass served as controls.

Results

The women in the control group and study groups had statistically similar gestational age at delivery, birth weight and preterm delivery (p > 0.05 for all). Miscarriage was significantly more frequent in women undergoing surgery for adnexal mass during pregnancy (p = 0.001). The women who had surgery for adnexal mass during pregnancy, at the time of cesarean section and following delivery were statistically similar with respect to surgery type and histopathological diagnosis (p > 0.05 for both). Malignancy was detected in none of the patients who underwent surgery for adnexal mass during pregnancy. Acute abdomen was the indication for the emergency surgery in six patients (3.5%) who had surgery for adnexal mass during pregnancy. Four patients (2.4%) had surgery for adnexal mass during pregnancy due to the high index of suspicion for malignancy.

Conclusion

The risk of malignancy was relatively lower in this cohort of adnexal masses detected during pregnancy and cesarean delivery. Surgical management of adnexal masses should be postponed to postpartum period as such management leads to an increased risk of miscarriage. Unless there is a need for emergent surgery or cancer staging, vaginal delivery should be encouraged in women diagnosed with adnexal mass during pregnancy.
Literatur
1.
2.
Zurück zum Zitat Webb KE, Sakhel K, Chauhan SP, Abuhamad AZ (2015) Adnexal mass during pregnancy: a review. Am J Perinatol 32(11):1010–1016CrossRefPubMed Webb KE, Sakhel K, Chauhan SP, Abuhamad AZ (2015) Adnexal mass during pregnancy: a review. Am J Perinatol 32(11):1010–1016CrossRefPubMed
3.
Zurück zum Zitat Cathcart AM, Nezhat FR, Emerson J, Pejovic T, Nezhat CH, Nezhat CR (2023) Adnexal masses during pregnancy: diagnosis, treatment, and prognosis. Am J Obstet Gynecol 228(6):601–612CrossRefPubMed Cathcart AM, Nezhat FR, Emerson J, Pejovic T, Nezhat CH, Nezhat CR (2023) Adnexal masses during pregnancy: diagnosis, treatment, and prognosis. Am J Obstet Gynecol 228(6):601–612CrossRefPubMed
4.
Zurück zum Zitat Montes de Oca MK, Dotters-Katz SK, Kuller JA, Previs RA (2021) Adnexal masses in pregnancy. Obstet Gynecol Surv 76(7):437–450CrossRefPubMed Montes de Oca MK, Dotters-Katz SK, Kuller JA, Previs RA (2021) Adnexal masses in pregnancy. Obstet Gynecol Surv 76(7):437–450CrossRefPubMed
5.
6.
Zurück zum Zitat Cavaco-Gomes J, Jorge Moreira C, Rocha A, Mota R, Paiva V, Costa A (2016) Investigation and management of adnexal masses in pregnancy. Scientifica (Cairo) 2016:3012802PubMed Cavaco-Gomes J, Jorge Moreira C, Rocha A, Mota R, Paiva V, Costa A (2016) Investigation and management of adnexal masses in pregnancy. Scientifica (Cairo) 2016:3012802PubMed
7.
Zurück zum Zitat Testa AC, Mascilini F, Quagliozzi L, Moro F, Bolomini G, Mirandola MT, Moruzzi MC, Scambia G, Fagotti A (2021) Management of ovarian masses in pregnancy: patient selection for interventional treatment. Int J Gynecol Cancer 31(6):899–906CrossRefPubMed Testa AC, Mascilini F, Quagliozzi L, Moro F, Bolomini G, Mirandola MT, Moruzzi MC, Scambia G, Fagotti A (2021) Management of ovarian masses in pregnancy: patient selection for interventional treatment. Int J Gynecol Cancer 31(6):899–906CrossRefPubMed
8.
Zurück zum Zitat American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology (2016) Practice bulletin no. 174: evaluation and management of adnexal masses. Obstet Gynecol 128(5):e210–e226 American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology (2016) Practice bulletin no. 174: evaluation and management of adnexal masses. Obstet Gynecol 128(5):e210–e226
9.
Zurück zum Zitat Zou G, Xu P, Zhu L, Ding S, Zhang X (2020) Comparison of subsequent pregnancy outcomes after surgery for adnexal masses performed in the first and second trimester of pregnancy. Int J Gynaecol Obstet 148(3):305–309CrossRefPubMed Zou G, Xu P, Zhu L, Ding S, Zhang X (2020) Comparison of subsequent pregnancy outcomes after surgery for adnexal masses performed in the first and second trimester of pregnancy. Int J Gynaecol Obstet 148(3):305–309CrossRefPubMed
10.
Zurück zum Zitat Oprescu ND, Ionescu CA, Drăgan I, Fetecău AC, Said-Moldoveanu AL, Chirculescu R, Vlădăreanu S (2018) Adnexal masses in pregnancy: perinatal impact. Rom J Morphol Embryol 59(1):153–158PubMed Oprescu ND, Ionescu CA, Drăgan I, Fetecău AC, Said-Moldoveanu AL, Chirculescu R, Vlădăreanu S (2018) Adnexal masses in pregnancy: perinatal impact. Rom J Morphol Embryol 59(1):153–158PubMed
11.
Zurück zum Zitat Timmerman D, Testa AC, Bourne T, Ameye L, Jurkovic D, Van Holsbeke C, Paladini D, Van Calster B, Vergote I, Van Huffel S, Valentin L (2008) Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol 31(6):681–690CrossRefPubMed Timmerman D, Testa AC, Bourne T, Ameye L, Jurkovic D, Van Holsbeke C, Paladini D, Van Calster B, Vergote I, Van Huffel S, Valentin L (2008) Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol 31(6):681–690CrossRefPubMed
12.
Zurück zum Zitat Leiserowitz GS, Xing G, Cress R, Brahmbhatt B, Dalrymple JL, Smith LH (2006) Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol 101(2):315–321CrossRefPubMed Leiserowitz GS, Xing G, Cress R, Brahmbhatt B, Dalrymple JL, Smith LH (2006) Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol 101(2):315–321CrossRefPubMed
13.
Zurück zum Zitat Yazbek J, Salim R, Woelfer B, Aslam N, Lee CT, Jurkovic D (2007) The value of ultrasound visualization of the ovaries during the routine 11–14 weeks nuchal translucency scan. Eur J Obstet Gynecol Reprod Biol 132(2):154–158CrossRefPubMed Yazbek J, Salim R, Woelfer B, Aslam N, Lee CT, Jurkovic D (2007) The value of ultrasound visualization of the ovaries during the routine 11–14 weeks nuchal translucency scan. Eur J Obstet Gynecol Reprod Biol 132(2):154–158CrossRefPubMed
14.
Zurück zum Zitat Glanc P, Salem S, Farine D (2008) Adnexal masses in the pregnant patient: a diagnostic and management challenge. Ultrasound Q 24(4):225–240CrossRefPubMed Glanc P, Salem S, Farine D (2008) Adnexal masses in the pregnant patient: a diagnostic and management challenge. Ultrasound Q 24(4):225–240CrossRefPubMed
15.
Zurück zum Zitat Koo YJ, Kim TJ, Lee JE, Kwon YS, Kim HJ, Lee IH, Lim KT, Lee KH, Shim JU, Mok JE (2011) Risk of torsion and malignancy by adnexal mass size in pregnant women. Acta Obstet Gynecol Scand 90(4):358–361CrossRefPubMed Koo YJ, Kim TJ, Lee JE, Kwon YS, Kim HJ, Lee IH, Lim KT, Lee KH, Shim JU, Mok JE (2011) Risk of torsion and malignancy by adnexal mass size in pregnant women. Acta Obstet Gynecol Scand 90(4):358–361CrossRefPubMed
16.
Zurück zum Zitat Yen CF, Lin SL, Murk W, Wang CJ, Lee CL, Soong YK, Arici A (2009) Risk analysis of torsion and malignancy for adnexal masses during pregnancy. Fertil Steril 91(5):1895–1902CrossRefPubMed Yen CF, Lin SL, Murk W, Wang CJ, Lee CL, Soong YK, Arici A (2009) Risk analysis of torsion and malignancy for adnexal masses during pregnancy. Fertil Steril 91(5):1895–1902CrossRefPubMed
17.
Zurück zum Zitat Yu C, Wang J, Lu W, Xie X, Cheng X, Li X (2019) Analysis of adnexal mass managed during cesarean section. Adv Clin Exp Med 28(4):447–452CrossRefPubMed Yu C, Wang J, Lu W, Xie X, Cheng X, Li X (2019) Analysis of adnexal mass managed during cesarean section. Adv Clin Exp Med 28(4):447–452CrossRefPubMed
18.
Zurück zum Zitat Whitecar MP, Turner S, Higby MK (1999) Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. Am J Obstet Gynecol 181(1):19–24CrossRefPubMed Whitecar MP, Turner S, Higby MK (1999) Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. Am J Obstet Gynecol 181(1):19–24CrossRefPubMed
19.
Zurück zum Zitat Li X, Yang X (2011) Ovarian malignancies incidentally diagnosed during cesarean section: analysis of 13 cases. Am J Med Sci 341(3):181–184CrossRefPubMed Li X, Yang X (2011) Ovarian malignancies incidentally diagnosed during cesarean section: analysis of 13 cases. Am J Med Sci 341(3):181–184CrossRefPubMed
20.
Zurück zum Zitat Schmeler KM, Mayo-Smith WW, Peipert JF, Weitzen S, Manuel MD, Gordinier ME (2005) Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol 105(5 Pt 1):1098–1103CrossRefPubMed Schmeler KM, Mayo-Smith WW, Peipert JF, Weitzen S, Manuel MD, Gordinier ME (2005) Adnexal masses in pregnancy: surgery compared with observation. Obstet Gynecol 105(5 Pt 1):1098–1103CrossRefPubMed
21.
Zurück zum Zitat Lee GS, Hur SY, Shin JC, Kim SP, Kim SJ (2004) Elective vs. conservative management of ovarian tumors in pregnancy. Int J Gynaecol Obstet 85(3):250–254 Lee GS, Hur SY, Shin JC, Kim SP, Kim SJ (2004) Elective vs. conservative management of ovarian tumors in pregnancy. Int J Gynaecol Obstet 85(3):250–254
22.
Zurück zum Zitat Cagino K, Li X, Thomas C, Delgado D, Christos P, Acholonu U Jr (2021) Surgical management of adnexal masses in pregnancy: a systematic review and meta-analysis. J Minim Invasive Gynecol 28(6):1171–82.e2CrossRefPubMed Cagino K, Li X, Thomas C, Delgado D, Christos P, Acholonu U Jr (2021) Surgical management of adnexal masses in pregnancy: a systematic review and meta-analysis. J Minim Invasive Gynecol 28(6):1171–82.e2CrossRefPubMed
23.
Zurück zum Zitat Ye P, Zhao N, Shu J, Shen H, Wang Y, Chen L, Yan X (2019) Laparoscopy versus open surgery for adnexal masses in pregnancy: a meta-analytic review. Arch Gynecol Obstet 299(3):625–634CrossRefPubMedPubMedCentral Ye P, Zhao N, Shu J, Shen H, Wang Y, Chen L, Yan X (2019) Laparoscopy versus open surgery for adnexal masses in pregnancy: a meta-analytic review. Arch Gynecol Obstet 299(3):625–634CrossRefPubMedPubMedCentral
Metadaten
Titel
Adnexal masses and pregnancy: a single-center experience of 9 years
verfasst von
Rıza Dur
Erhan Demirdag
Ozge Yucel Celik
Ertugrul Karahanoglu
Gamze Dur
Cem Yagmur Ozdemir
Aykan Yucel
Ozlem Moraloglu Tekin
Publikationsdatum
05.05.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2024
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-024-07527-w

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Keine eingeschränkten Kassenleistungen bei Schwangerschaft nach IVF

Nach privat bezahlter In-vitro-Fertilisation muss die gesetzliche Krankenkasse ein Arzneimittel zum Erhalt der Schwangerschaft bezahlen, so ein Urteil des Sozialgerichts in München.

Medikamente verändern wohl Nährstoffzusammensetzung der Muttermilch

Einige Medikamente wie selektive Serotonin-Wiederaufnahmehemmer können offenbar die Makronährstoffzusammensetzung der Muttermilch verändern. Das birgt möglicherweise gesundheitliche Risiken für manche gestillte Kinder.

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Cannabisextrakt verbessert Antiemese bei Chemotherapie

Sprechen Krebskranke auf die übliche Antiemese während einer Chemotherapie nicht ausreichend an, lohnt sich möglicherweise eine Behandlung mit Cannabisextrakt. In einer Phase-2/3-Studie ließ sich die antiemetische Response mit einem solchen Extrakt erheblich verbessern.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.